osmium tetroxide has been researched along with soblidotin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Isowa, K; Kato, H; Kuwayama, N; Mimura, Y; Mitsuishi, M; Morimoto, H; Murakoshi, M; Nakayama, T; Ogawa, T; Toyoshi, T | 1 |
1 other study(ies) available for osmium tetroxide and soblidotin
Article | Year |
---|---|
An antimicrotubule agent, TZT-1027, does not induce neuropathologic alterations which are detected after administration of vincristine or paclitaxel in animal models.
Topics: Animals; Antineoplastic Agents; Coloring Agents; Hematoxylin; Male; Mice; Microtubules; Models, Animal; Oligopeptides; Osmium Tetroxide; Paclitaxel; Peripheral Nerves; Rabbits; Sciatic Nerve; Spinal Cord; Tolonium Chloride; Vincristine | 2001 |